Clinical Trial Update: S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

A phase 2 trial evaluated docetaxel with or without vandetanib in patients with persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or pri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Vandetanib (vandetanib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-12-19